Concepedia

Cai-Hong Yun

CY

3

Publications

748

Citations

3

H-Index

2013

Active since

Affiliations

Peking University(Current)

Massachusetts General Hospital

Harvard University

Dana-Farber Cancer Institute

Cai-Hong Yun is an author at Peking University specializing in tumor biology, medicinal chemistry, and drug discovery.

Top concepts

MedicinePharmacologyBreast CancerTumor BiologyDrug DiscoveryPharmacotherapyChemical BiologyDrug DevelopmentNatural SciencesMolecular Biology

Publications per year

2013–2017

3

Publications

3

Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer

Hiroyuki Yasuda, Eunyoung Park, Cai-Hong Yun et al. · Science Translational Medicine · 2013 · 548 citations · Full text

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Li Tan, Jun Wang, Junko Tanizaki et al. · Proceedings of the National Academy of Sciences · 2014 · 175 citations · Full text

Covalent Inhibitors, Fgfr Inhibitors, Human Fgf Receptors +18

Structure Based Design of <i>N</i>-(3-((1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors

Yu Chang, Xiaoyun Lu, Marthandam Asokan Shibu et al. · Journal of Medicinal Chemistry · 2017 · 25 citations · Full text

Rows per page

1–3 of 3